nor

Crypto.com Surpasses 100 Million Global Users

Source Node:
Time Stamp: May 6, 2024 6:06 AM - Modified On: May 6, 2024 - Published By:
Source Cluster:
Republished By Plato

New Major Milestone Reached Following Latest Marketing Campaign Sydney, May 6, 2024 - Crypto.com today announced it has surpassed the 100 million global user mark – the latest significant milestone for the company founded in 2016 and the industry leader in regulatory compliance, security and privacy. This milestone was reached in the immediate wake of Crypto.com’s latest Fortune Favors the Brave brand film, INEVITABLE, which celebrates conviction, achievement against all odds and staying focused on the additional goals ahead. Crypto.com’s user base has doubled since the first Formula 1 Crypto.com

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:22 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating